Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Broadcom Inc. stock logo
AVGO
Broadcom
$414.96
-2.5%
$351.15
$203.69
$437.68
$1.96T1.4324.96 million shs9.67 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$972.70
-1.5%
$945.26
$623.78
$1,133.95
$915.60B0.483.18 million shs1.10 million shs
Microsoft Corporation stock logo
MSFT
Microsoft
$421.78
+1.9%
$396.15
$356.28
$555.45
$3.13T1.135.38 million shs18.13 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Broadcom Inc. stock logo
AVGO
Broadcom
-0.45%+4.93%+35.31%+37.01%+112.62%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-0.15%+15.95%+6.65%-3.22%+27.21%
Microsoft Corporation stock logo
MSFT
Microsoft
+0.68%-2.44%+11.05%+5.19%-4.43%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Broadcom Inc. stock logo
AVGO
Broadcom
$414.96
-2.5%
$351.15
$203.69
$437.68
$1.96T1.4324.96 million shs9.67 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$972.70
-1.5%
$945.26
$623.78
$1,133.95
$915.60B0.483.18 million shs1.10 million shs
Microsoft Corporation stock logo
MSFT
Microsoft
$421.78
+1.9%
$396.15
$356.28
$555.45
$3.13T1.135.38 million shs18.13 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Broadcom Inc. stock logo
AVGO
Broadcom
-0.45%+4.93%+35.31%+37.01%+112.62%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-0.15%+15.95%+6.65%-3.22%+27.21%
Microsoft Corporation stock logo
MSFT
Microsoft
+0.68%-2.44%+11.05%+5.19%-4.43%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Broadcom Inc. stock logo
AVGO
Broadcom
2.94
Moderate Buy$435.304.90% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.87
Moderate Buy$1,217.5925.18% Upside
Microsoft Corporation stock logo
MSFT
Microsoft
2.87
Moderate Buy$562.4433.35% Upside

Current Analyst Ratings Breakdown

Latest MSFT, LLY, and AVGO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Reiterated RatingBuy
5/6/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Boost Price TargetBuy$595.00 ➝ $680.00
5/5/2026
Microsoft Corporation stock logo
MSFT
Microsoft
DowngradeMarket Perform
5/5/2026
Microsoft Corporation stock logo
MSFT
Microsoft
UpgradeBuyHold
5/5/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingBuy$1,183.00
5/5/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Boost Price TargetBuy$730.00 ➝ $870.00
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
UpgradeBuy (B-)Buy (B)
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOutperform$1,325.00
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetOverweight$1,350.00 ➝ $1,400.00
5/4/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Lower Price TargetBuy$630.00 ➝ $550.00
5/4/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Reiterated RatingBuy
(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Broadcom Inc. stock logo
AVGO
Broadcom
$63.89B30.75$7.48 per share55.48$17.15 per share24.20
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$72.25B12.68$24.73 per share39.34$33.13 per share29.36
Microsoft Corporation stock logo
MSFT
Microsoft
$281.72B11.12$18.75 per share22.49$55.78 per share7.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Broadcom Inc. stock logo
AVGO
Broadcom
$23.13B$5.1281.0525.410.8836.57%38.61%17.49%6/3/2026 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$28.1534.5422.431.0834.98%105.77%23.76%N/A
Microsoft Corporation stock logo
MSFT
Microsoft
$101.83B$16.8025.1021.881.4839.34%31.94%18.47%N/A

Latest MSFT, LLY, and AVGO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/3/2026Q2 2026
Broadcom Inc. stock logo
AVGO
Broadcom
$2.40N/AN/AN/A$22.02 billionN/A
4/30/2026Q1 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.97$8.55+$1.58$8.26$17.82 billion$19.80 billion
4/29/2026Q3 2026
Microsoft Corporation stock logo
MSFT
Microsoft
$4.06$4.27+$0.21$4.27$81.44 billion$82.89 billion
3/4/2026Q1 2026
Broadcom Inc. stock logo
AVGO
Broadcom
$2.03$2.05+$0.02$1.50$19.10 billion$19.31 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Broadcom Inc. stock logo
AVGO
Broadcom
$2.600.63%+12.67%50.78%15 Years
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.71%+15.18%24.58%11 Years
Microsoft Corporation stock logo
MSFT
Microsoft
$3.640.86%+10.24%21.67%23 Years

Latest MSFT, LLY, and AVGO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/10/2026
Microsoft Corporation stock logo
MSFT
Microsoft
quarterly$0.910.9%5/21/20265/21/20266/11/2026
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.72%5/15/20265/15/20266/10/2026
3/3/2026
Broadcom Inc. stock logo
AVGO
Broadcom
Quarterly$0.650.81%3/23/20263/23/20263/31/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Broadcom Inc. stock logo
AVGO
Broadcom
0.80
1.90
1.73
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.26
1.50
1.10
Microsoft Corporation stock logo
MSFT
Microsoft
0.08
1.28
1.27

Institutional Ownership

CompanyInstitutional Ownership
Broadcom Inc. stock logo
AVGO
Broadcom
76.43%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
Microsoft Corporation stock logo
MSFT
Microsoft
71.13%

Insider Ownership

CompanyInsider Ownership
Broadcom Inc. stock logo
AVGO
Broadcom
1.90%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
Microsoft Corporation stock logo
MSFT
Microsoft
0.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
Broadcom Inc. stock logo
AVGO
Broadcom
33,0004.73 billion4.64 billionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000941.74 million940.42 millionOptionable
Microsoft Corporation stock logo
MSFT
Microsoft
228,0007.43 billion7.43 billionOptionable

Recent News About These Companies

Microsoft: Azure Doing The Heavylifting
The Morning Trade: CRWV
Microsoft's AI Transition Changes Everything Again

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Broadcom stock logo

Broadcom NASDAQ:AVGO

$414.96 -10.48 (-2.46%)
As of 01:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing custom silicon solutions; serializer/deserializer application specific integrated circuits; optical and copper, and physical layer devices; and fiber optic components and RF semiconductor devices. The company also offers RF front end modules and filter; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; inductive charging; attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; optocouplers, industrial fiber optics, and motion control encoders and subsystems; light emitting diode, ethernet PHYs, switch ICs, and camera microcontrollers. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was founded in 1961 and is headquartered in Palo Alto, California.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$972.70 -14.35 (-1.45%)
As of 01:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Microsoft stock logo

Microsoft NASDAQ:MSFT

$421.78 +7.82 (+1.89%)
As of 01:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.